A Prospective, Single Center, Single-arm Study on the Efficacy and Safety of Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Latest Information Update: 17 Oct 2024
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin (Primary) ; Romiplostim (Primary)
- Indications Aplastic anaemia
- Focus Therapeutic Use
- Acronyms IH-ROMIST
- 17 Oct 2024 New trial record